Wake Forest University Baptist Medical Center
CareersFind a DoctorMake an AppointmentDepartmentsDirections & ParkingGiftsContact UsPRINT
 


WFUBMC Home  >   Infectious Diseases  >   Faculty  >   Robert Shereetz :: Curriculum Vitae


View CV

ROBERT J. SHERERTZ, MD
Chief, Infectious Diseases
Associate Hospital Epidemiologist

Section on Infectious Disease
Wake Forest University School of Medicine
Medical Center Boulevard
Winston Salem, NC 27157 - 1042

Phone: 336.716.4584
Fax: 336.716.3825

CURRICULUM VITAE

CURRENT ACADEMIC TITLE:
Professor of Internal Medicine
Section Head of Infectious Diseases
Associate Hospital Epidemiologist

ADDRESS:
Business: Department of Internal Medicine
Section on Infectious Diseases
Wake Forest University School of Medicine
Medical Center Boulevard
Winston-Salem, North Carolina 27157-1042

Telephone: (336) 716-4584
Telefax: (336) 716-3825

E-mail: sherertz@wfubmc.edu

EDUCATION:
B.S., (Mathematics) 1968-1972 Wake Forest University, Winston-Salem, NC, Magna Cum Laude

M.D., 1972-1976 University of Virginia School of Medicine, Charlottesville, VA

Post-Doctoral Training:
1976-1977 Intern in Medicine, University of Virginia School of Medicine, Charlottesville, VA
1977-1979 Resident in Medicine, University of Virginia School of Medicine, Charlottesville, VA
1979-1982 Fellow, Infectious Diseases Section, University of North Carolina School of Medicine, Chapel Hill, NC

Specialty Certification:
September 1979 Internal Medicine
November 1982 Infectious Diseases

Promotion and Tenure:
1987-1988 Associate Professor/Tenured, University of Florida School of Medicine
1996-Present Professor of Medicine (Infectious Diseases), Wake Forest University School of Medicine
2000 Tenured, Wake Forest University School of Medicine

EDITORIAL WORK:

Journal Reviewer:
1989 Infection & Immunity
1989-Present Archives Internal Medicine
1990-Present Infection Control Hospital Epidemiology
1990-Present American Journal of Medicine
1991-Present JAMA
1992-Present Clinical Infectious Diseases
1992-Present Medical Microbiology
1992-Present Journal of Infectious Diseases
1994-Present Annals of Internal Medicine

OTHER PROFESSIONAL APPOINTMENTS AND ACTIVITIES:
1982-1988 Hospital Epidemiologist, Shands Hospital, Gainesville FL
1988-2000 Hospital Epidemiologist, North Carolina Baptist Hospital, Winston-Salem NC
1990-1992 Chairperson, Surgical Wound Infection Task Force
Participating Organizations:

Society for Hospital Epidemiologists of America
Association for Practitioners of Infection Control
Surgical Infection Society
Centers for Disease Control

1994 Consultant for the preparation of the section on Trials for I.V. Device -Associated Bacteremia/Fungemia" within the larger scope of the European Guidelines for Anti-infective Trials.
1995 Reviewer, Guideline for the Prevention of Intravascular Device-Related Infections, Centers for Disease Control
1997 Member, SHEA Nominations committee
1997-1998 After-School Science Program for middle school children (200 children)
1998-2000 Member, IDSA Committee, Guidelines for the Management of Catheter-Related Infections
1999 Chairperson, Nephrology Chief Search Committee

GRADUATE STUDENT THESIS COMMITTEES:
1990-1992 Chairperson, Kate Gledhill's Master's Thesis Committee
1992-1993 Member, Rebecca Tart's Ph.D. Thesis Committee
1995-1996 Member, Kevin High's Masters Thesis Committee

PROFESSIONAL MEMBERSHIPS:
1980-Present American Society for Microbiology
1982-Present Society of Hospital Epidemiologists of America
1983-Present American Practitioners of Infection Control
1986-Present Infectious Disease Society of America
1990-Present American Federation of Clinical Research

HONORS AND AWARDS:
Phi Beta Kappa
1986 President-Elect of the Nosocomial Infections Division
1987 President of the Nosocomial Infections Division

PROFESSIONAL INTERESTS:

  • Pathogenesis and prevention of foreign body infections
  • Transmission of Staphylococcus aureus infections
  • Transmission of other nosocomial infections
  • Science education of children

GRANTS:

Active
PI, NIH, RO1 AI-46558-01A1 7/1/00-6/30/04 30% effort
The Cloud Adult $1,918,372

Submitted
Co-PI, CDC 10/1/00-9/30/05 20% effort
Problem Pathogen Partnership $4,000,000

PATENTS:
M/EDTA Pharmaceutical Preparations & Uses Thereof

Flush Solution
Patent #5,362,754
Filing Date: 11/12/92
Date of Issue: 11/8/94

Coating for Medical Devices
Patent #5,688,516
Filing Date: 11/12/92
Date of Issue: 11/18/97

BIBLIOGRAPHY:
Books:

  1. The Practice of Infection Control. Sherertz RJ, ed., 1997.

CHAPTERS IN BOOKS:

  1. Sherertz RJ, Sherertz EF. Chemistry of the pesticides. In: Williams AJ, McConnell WC, eds. Pesticides: a comparison of chlorinated hyrocardon pesticide residues in mammals from the piedmont and mountain of North Carolina. National Science Foundation - S.O.S. Grant #9195, 1971.
  2. Sherertz RJ. Management of infections in the burn patient. In: Salisbury RE, Newman NM, Dingeldein GP, eds. Manual of burn therapeutics: an interdisciplinary approach. Boston: Little, Brown and Co., 1983:37-59.
  3. .Sherertz RJ. Isolation practices. In: Salisbury RE, Newman NM, Dingeldein GP, eds. Manual of burn therapeutics: an interdisciplinary approach. Boston: Little, Brown and Co., 1983:267-271.
  4. Sherertz RJ, Hampton L. Infection control practice in hospital employee health. In: Wenzel RP, ed. Prevention and control of hospital acquired infections. Baltimore: Williams and Wilkins, 1986.
  5. Sherertz RJ, Morosok RD, Streed SA. Infection control aspects of hospital employee health. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections, Williams & Wilkins, 1993:295-332.
  6. Gilmore IM, Sherertz RJ. In: Hoeprich PD, Jordan MC, Ronald AR, ed. Infections following surgical operations. Chapter 176. Philadelphia: Lippincott Co., 1994.
  7. Streed SA, Sherertz RJ. Hospital Administration. In: Sherertz RJ, Streed SA, Gledhill KS, eds. The Practice of Infection Control, BGSM/NCBH, 1995.
  8. Sherertz RJ, Streed SA. Medical, Nursing, Other Staff. In: Sherertz RJ, Streed SA, Gledhill KS, eds. The Practice of Infection Control, BGSM/NCBH, 1995.
  9. Sherertz RJ. Surveillance of nosocomial urinary tract infections. In: Sherertz RJ, Streed SA, Gledhill KS, eds. The Practice of Infection Control, BGSM/NCBH, 1995.
  10. Sherertz RJ. Surveillance of nosocomial pneumonias. In: Sherertz RJ, Streed SA, Gledhill KS, eds. The Practice of Infection Control, BGSM/NCBH, 1995.
  11. Sherertz RJ. Surveillance of nosocomial bloodstream infections. In: Sherertz RJ, Streed SA, Gledhill KS, eds. The Practice of Infection Control, BGSM/NCBH, 1995.
  12. Sherertz RJ. Management of infections or exposures to infections in hospital personnel. In: Sherertz RJ, Streed SA, Gledhill KS, eds. The Practice of Infection Control, BGSM/NCBH, 1995.
  13. Sherertz RJ. Tuberculosis. In: Sherertz RJ, Streed SA, Gledhill KS, eds. The Practice of Infection Control, BGSM/NCBH, 1995.
  14. Sherertz RJ. Pathogenesis of vascular catheter infections. In: Seifert H, Jansen B, Farr B. Catheter Related Infections. Marcel Dekker, 1995.
  15. Sherertz RJ, Streed SA, Reagan DR. Computers in hospital epidemiology and infection control. In: Mayhall CG. ed. Hospital Epidemiology and Infection Control. 1995.
  16. Streed SA, Gledhill KS, Sherertz RJ. Surgical site infections. APIC Curriculum. 1995.
  17. Sherertz RJ. Vascular catheter infection surveillance. SHEA Manual for Hospital Epidemiologists. 1995.
  18. Sherertz RJ. Staphylococcus aureus. In: Sherertz RJ, ed. The Practice of Infection Control, BGSM/NCBH. 1995.
  19. Sherertz RJ. Escherichia coli. In: Sherertz RJ, ed. The Practice of Infection Control, BGSM/NCBH. 1995.
  20. Sherertz RJ. Klebsiella. In: Sherertz RJ, ed. The Practice of Infection Control, BGSM/NCBH. 1995.
  21. Sherertz RJ. Other mycobacteria. In: Sherertz RJ, ed. The Practice of Infection Control, BGSM/NCBH. 1995.
  22. Sherertz RJ. Other viruses. In: Sherertz RJ, ed.. The Practice of Infection Control, BGSM/NCBH. 1995.
  23. Sherertz RJ. Ants, maggots, etc. In: Sherertz RJ, Streed SA, Gledhill KS, eds. The Practice of Infection Control, BGSM/NCBH. 1995.
  24. Sherertz RJ. Other gram positive bacteria. In: Sherertz RJ, ed. The Practice of Infection Control, BGSM/NCBH. 1996.
  25. Sherertz RJ. Prevention and control of nosocomial pneumonias. In: Sherertz RJ, ed. The Practice of Infection Control, BGSM/NCBH. 1996.
  26. Lewis WJ, Sherertz RJ. Septic phlebitis: graft and vascular infections. Korsienowski O, ed. In: Cardiovascular Infections of the Atlas of Infectious Diseases. Current Medicine, in press, 1997.
  27. Sherertz RJ. Vascular catheter infection surveillance. Herwaldt L, ed. In: A Practical handdbook for Hospital Epidemiologists. Slack, Inc, 1997.
  28. Sherertz RJ. Pathogenesis of vascular catheter infections. Seifert H, Jansen B, Farr BM, eds. In: Catheter-related infections. Marcel Dekker, Inc., New York, 1997, pp. 1-29.
  29. Lewis WJ, Sherertz RJ. Endovascular infections: native blood vessel, catheter-related and graft infectionsl Ed. by Mandel GL, Korzenvowski. In Atlas of Infectious Diseases, Current Medicine, Philadelphia, PA, 1998.
  30. Sherertz RJ. Pathogenesis of vascular catheter infections. Waldvoget FA, Bisno AL, ed. In: Infections Associated with Indwelling Medical Devices. American Society for Microbiology. In Press.

JOURNAL ARTICLES:

  1. Sherertz RJ, Dacey R, Sande MA. Cefamandole in the therapy of experimental pneumococcal meningitis. J Antimicrob Chemother 1976;2:159-165.
  2. Sande MA, Sherertz RJ, Zak O, Strausbaugh LJ. Cephalosporin antibiotics in therapy of experimental streptococcus pneumoniae and haemophilus influenzae meningitis in rabbits. J Infect Dis 1978;137:S161-S168.
  3. Sande MA, Sherertz RJ, Zak O, Dacey RG, Bodine JA, Strausbaugh LJ. Factors influencing the penetration of antimicrobial agents into the cerebrospinal fluid of experimental animals. Scand J Infect Dis 1978;Suppl 14:160-163.
  4. Rutledge R, Baker VV, Sherertz R, Johnson G Jr. Rifampin and cefazolin as prophylactic agents: a comparison in an animal model of vascular graft infection. Arch Surg 1982;117:1164-1165.
  5. Sherertz RJ, Sarubbi FA. The prevalence of Clostridium difficile and toxin in a nursery population: a comparison between patients with necrotizing enterocolitis and an asymptomatic group. J Pediatr 1982;100:435-439.
  6. Burke JT, Wargin WA, Sherertz RJ, Sanders KL, Blum MR, Sarubbi FA. Pharmacokinetics of intravenous chloramphenicol sodium succinate in adult patients with normal renal and hepatic function. J Pharm Biopharm 1982;10:601-614.
  7. Sherertz RJ, Falk RJ, Huffman KA, Thomann CA, Mattern WD. Infections associated with subclavian Uldall catheters. Arch Intern Med 1983;143;52-56.
  8. Sherertz RJ, Sarubbi FA. A three-year study of nosocomial infections associated with pseudomonas aeruginosa. J Clin Microbiol 1983;18:160-164.
  9. Rutala WA, Katz BS, Sherertz RJ, Sarubbi FA. Environmental study of a methicillin-resistant Staphylococcus aureus epidemic in a burn unit. J Clin Microbiol 1983;18:683-688.
  10. Huffman KA, Sherertz RJ, Mattern WD. An appraisal of the subclavian dialysis catheter. Int J Artif Organs 1983;6:176-177.
  11. Sherertz RJ, Peacock JE, Sixbey JW, Folds JD, Bowdre JH, Huang E-S, Hamilton JD, McDowell DL. Nonurban male homosexuals: epidemiologic, immunologic, and virologic characteristics. Am J Med Sci 1984;288:109-113.
  12. Sherertz RJ, Russell BA, Reuman PD. Transfusion of hepatitis A by transfusion of blood products. Arch Intern Med 1984;144:1579-1580.
  13. Sherertz RJ, Sullivan ML. An outbreak of Acinetobacter calcoacetieus in burn patients: contamination of patients' mattresses. J Infect Dis 1985;151:252-258.
  14. Sherertz RJ. AIDS: a perspective for the medical practitioner. Med Clin North Am 1985;69:637-655.
  15. Belani A, Sherertz R, Sullivan ML, Russell BA, Reuman PD. Outbreak of staphylococcal infection in two hospital nurseries traced to a single nasal carrier. Infect Control 1986;7:487-490.
  16. Heard SO, Davis RF, Sherertz RJ, Michail MS, Gallager RC, Layon AJ, Gallagher TJ. Influence of sterile protective sleeves on the sterility of pulmonary artery catheters. Crit Care Med 1987;15:499-502.
  17. Ekenna O, Sherertz RJ. Factors affecting Candida albicans from the gastrointestinal tract of mice. Infect Immun 1987;55:1558-1563.
  18. Sherertz RJ, Belani A, Kramer BS, Elfenbein GJ, Weiner RS, Sullivan ML, Thomas RG, Samsa GP. Impact of air filtration on nosocomial aspergillus infections: unique risk of bone marrow transplant recipients. Am J Med 1987;83:709-718.
  19. Solomon DD, Sherertz RJ. Antibiotic releasing polymers. J Controlled Release 1987;6:343-352.
  20. Raad II, Sherertz RJ, Loveless MO, Carillo C, O'Connor RP, Miller M, Mostow SR. Comparison of cefpimizole with cefotaxime and penicillin G for treatment of uncomplicated gonorrhea. Sex Transm Dis 1988;15:73-77.
  21. Hampton AA, Sherertz RJ. Vascular-access infections in hospitalized patients. Surg Clin North Am 1988;68(Feb):57-71.
  22. Sherertz RJ, Forman DM, Solomon DD. Efficacy of dicloxacillin coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice. Antimicrob Ag Chemother 1989;33:1174-1178.
  23. Raad II, Sherertz RJ, Rains CS, Cusick JL, Faverbach LL, Revman PD, Belevore TR. The importance of nosocomial transmission of measles in the propagation of a community outbreak. Infect Control Hosp Epidemiol 1989;10:161-166.
  24. Raad I, Cusick J, Sherertz RJ, Sabbagh M, Howell N. Annual tuberculin skin testing of employees at a university hospital: a cost-benefit analysis. Infect Control Hosp Epidemiol 1989;10:465-469.
  25. Sherertz RJ, Raad II, Belani A, Koo LC, Rand KH, Pickett DL, Straub SA, Faverbach LL. Three year experience with sonication vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990;28:76-82.
  26. Raad II, Sherertz RJ, Russell BA, Reuman PD. Uncontrolled nosocomial rotavirus transmission during a community outbreak. Am J Inf Contr 1990;18:24-28.
  27. Sherertz RJ, Gledhill KS, Hampton KD, Pfaller MA, Givner LB, Abramson JS, Dillard RG. Outbreak of Candida bloodstream infections in a neonatal intensive care unit associated with retrograde medication administration. J Pediatrics 1992;120:455-461.
  28. Raad I, Sabbagh M, Rand KH, Sherertz RJ. Quantitative tip culture methods and the diagnosis of central venous catheter related infections. Diagn Microb Infect Dis 1992;15:13-20.
  29. Ramphal R, Bolger M, Oblon DJ, Sherertz RJ, Malone JD, Rand KH, Gillion M, Shands JW, Kramer BS. Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study. Antimicrob Ag Chemother 1992;36:1062-1067.
  30. Falk PS, Scuderi PE, Sherertz RJ, Motsinger SM. Infected radial artery pseudoaneurysms occurring after percutaneous cannulation. Chest 1992;101:490-495.
  31. Sherertz RJ, Carruth WA, Hampton AA, Byron MP, Solomon DD. Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis 1993;167:98-106.
  32. Ekenna O, Sherertz RJ, Bingham H. Natural history of bloodstream infections in a burn patient population: the importance of candidemia. Am J Infect Control 1993;21:189-195.
  33. Guzman R, Sherertz R. Ischuria, strangury, dysuria and the catheter. Patient Care 1993.
  34. Carruth WA, Byron MP, Solomon DD, White WL, Stoddard GJ, Marasok RD, Sherertz RJ. Subcutaneous, catheter-related inflammation in a rabbit model correlates with peripheral vein phlebitis in human volunteers. J Biomed Mater Res 1994;28:259-267.
  35. Sherertz RJ, Streed SA. Medical devices: Significant risk vs. nonsignificant risk. JAMA 1994;272:955-956.
  36. Birnbaum D, Herwaldt L, Low DE, Noble M, Pfaller M, Sherertz R, Chow AW. Efficacy of microbial identification system for epidemiologic typing of coagulase-negative Staphylococci. J Clin Microbiol 1994;32:2113-2119.
  37. Sherertz RJ, Carruth WA, Marosok RD, Espeland MA, Solomon DD. Contribution of vascular catheter material to the pathogenesis of infection: The enhanced risk of silicone elastomer in vivo. J Biomed Mater Res 1995;29:635-45.
  38. Morosok R, Washburn R, Indorf A, Solomon D, Sherertz R. Contribution of vascular catheter material to the pathogenesis of infection: Depletion of complement by silicone elastomer in vitro. J Biomed Mater Res 1995;30:245-250.
  39. Sherertz RJ. Vascular catheter infection surveillance. Infection Control and Hosp. Epidemiol 1996;17:746-752.
  40. Sherertz RJ, Reagan DR, Hampton KD, Robertson KL, Streed SA, Hoen HM, Thmas R, Gwaltney JR Jr. A cloud adult: the Staphylococcus aureus - virus interaction revisited. Ann Intern Med 1996;124:539-547.
  41. Sherertz RJ, Heard SO, Raad IS, Gentry L, Bowton D, Scuderi P, Hu J, Carruth W, Satishchandra B, Pepe J, Mosenthal A, Burke T, Dupuis J. Gamma radiation-sterilized, triple-lumen catheters coated with a low concentration of chlorhexidine were not efficacious at preventing catheter infections in intensive care unit patients. Antimicrob Agents Chemother 1996;40:1995-1997.
  42. Raad I, Buzaid A, Rhyne J, Hachem R, Daroviche R, Sefar H, Albitar M, Sherertz RJ. Minocycline and EDTA for the prevention of recurrent vascular catheter infections. Clin infect Dis 25:149-151, 1997.
  43. Lewis WJ, Sherertz RJ. Microbial interactions with catheter material. Nutrition (suppl) 13:5S-9S, 1997.
  44. Sherertz RJ. Selected thoughts on the development of new medical devices. Current Opin Infect Dis 10:330-334, 1997.
  45. Sherertz RJ, Heard SO, Raad II. Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication, and flushing methodologies. J Clin Microbiol 1997;35:641-646.
  46. Sherertz R. Look before your leap: discontinuation of an infusion therapy team. Infect Control Hosp Epidemiol 1999;20:99-100.
  47. Indorf AS, Poate T, Sherertz RJ. Neutrophil chemotaxis on silicone and polyurethane surfaces. J Infect Dis 1999;180:1603-1607.
  48. Sherertz RJ, Ely EW, Westbrook DM, Gledhill KS, Streed SA, Kiger B, Flynn L, Hayes S, Strong S, Cruz J, Bowton DL, Hulgan T, Haponik EF. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000; 132:641-648.
  49. Mermel L, Sherertz RJ, Raad II, Farr BM, O’Grady N, Harris JS, Craven DE. IDSA Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2000, in press.

Abstracts:

  1. Sherertz RJ, Becker V. Membrane resting potentials in crayfish as affected by ion selectivity and metabolic inhibitors. Presented at the North Carolina Academy of Science Meeting, Greenville, North Carolina, April 1972.
  2. Sherertz R, Dacey R, Sande M. Cephalosporin therapy of experimental meningitis. Clin Res 1975;23:30A.
  3. Strausbaugh LJ, Mandaleris CD, Sherertz RJ, Sande MA. In vivo antagonism between gentamicin and chloramphenicol in rabbits with gram-negative meningitis. Clin Res 1975;23:312A.
  4. Carlson JR, Sherertz RJ, Sarubbi FA Jr. Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic susceptibilities and phage patterns. Abstr Annu Meet Am Soc Microbiol 1981;300.
  5. Burke JT, Wargin WA, Sanders KL, Blum MR, Sarubbi FA, Sherertz RJ. A pharmacokinetic study of chloramphenicol sodium succinate in adult patients with normal renal and hepatic function after multiple intravenous infusions. Presented at the First European Congress of Biopharmaceutics and Pharmacokinetics, Clermont-Ferrand, France, April 1981. Abstract #306.
  6. Sherertz RJ, Marshall RL, Sarubbi FA. Clostridium difficile (Cd): a pathogen in neonates? Interscience Congress on Antimicrobial Agents and Chemotherapy, 1981;707.
  7. Sherertz RJ, Falk RJ, Huffman KA, Mattern WD, Thomann CA. Infections associated with Uldall catheters (ac). Abstr Annu Meet Am Soc Microbiol 1982;82.
  8. Katz BS, Rutala WA, Sherertz RJ, Sarubbi FA. Environmental investigation of methicillin resistant staphylococcus aureus (MRSA) epidemic in a burn unit. Abstr Annu Meet Am Soc Microbiol 1982;84.
  9. Sherertz RJ, Wargin WA, Burke JT, Sarubbi FA. Liver function tests (LFT) as predictors of abnormal chloramphenicol (C) pharmacokinetics (PK). Presented at the 22nd Interscience Congress on Antimicrobial Agents and Chemotherapy, Miami, Florida, October 1982. Abstracts of the Interscience Congress on Antimicrobial Agents and Chemotherapy 1982;76.
  10. Sherertz R, Peacock J, Sixby J, Folds J, Bowdre J, Huang E, Hamilton J, McDowell D. Epidemiologic, immunologic and virologic characteristics of 22 nonurban male homosexuals. Clin Res 1983;31:375A.
  11. Russell BA, Sherertz RJ, Cuddeback JK, Reuman PD. Nosocomial transmission of hepatitis A by blood components. Abstr Annu Meet Am Soc Microbiol 1983;104.
  12. Sullivan ML, Sherertz RJ, Russell BA, Rand KH, Herman K, Gutekunst RR. Pseudo-outbreak of nosocomial rubella due to false positive IgM serology. Abstr Annu Meet Am Soc Micrbiol 1983;105.
  13. Sherertz RJ, Sullivan ML. An outbreak of Acinctobacter calcoaceticus (AC) infections in burn patients due to contamination of patient mattresses with the organism. Presented at the 23rd International Congress on Antimicrobial Agents and Chemotherapy. Las Vegas, Nevada, October, 1983. Abstract #823.
  14. Sherertz RJ, Wilson MB, Sarubbi FA. Epidemiology of methicillin-resistant Staphylococcus aureus: survival advantage in a burn unit. Presented at the 23rd International Congress on Antimicrobial Agents and Chemotherapy, Las Vegas, Nevada, October 1983. Abstract #637.
  15. Sherertz RJ, Sarubbi FA. Correlation of therapy of methicillin resistant staphylococcus aureus (MRSA) infections using cephalosporins (C) with in vitro sensitivity testing. Abstr Annu Meet Am Soc Microbiol 1984;10.
  16. Reuman P, Duckworth D, Sherertz R, Ayoub E. Epidemiology of gentamicin resistant gram negative rods in stools (GRGNS) of hospitalized children (HC). Abstr Annu Meet Am Soc Microbiol 1984;309.
  17. Heard SO, Davis RF, Sherertz RJ, Gallagher RC, Layon AJ, Gallagher TJ. Efficacy of sterile protective sleeves in maintaining sterility of pulmonary artery catheters after insertion. Presented at the Society of Cardiovascular Anesthesiologists. Richmond, Virginia, May 1984.
  18. Russell B, Sherertz R, Reuman P, Sullivan M. Nosocomial rotavirus outbreak parallels community infections. Presented at the 11th Annual Association for Practitoners in Infection Control Conference. Washington, DC, May 1984.
  19. Sullivan M, Sherertz R, Reuman P, Russell B. Simultaneous Staphylococcus aureus nursery outbreaks in a community and a university teaching hospital traced to one nurse. Presented at the 11th Annual Association for Practitioners in Infection Control Conference. Washington, DC, May 1984.
  20. Heard SO, Davis RF, Sherertz RJ, Gallagher RC, Layon AJ, Mikhail MS, Gallagher TJ. Sterility of pulmonary artery catheters with sterile protective sleeves and the incidence of catheter-related bacteremia. Anesthesiology 1984;61:A154.
  21. Ekenna O, Sherertz RJ. Natural history of candidemia in a burn patient population. Presented at the 24th International Congress on Antimicrobial Agents and Chemotherapy. Washington, DC, October 1984, Abstract #1165.
  22. Forman DM, Sherertz RJ, Johnson R, Koo LC, Heard SO. Importance of organism adherence in the pathogenesis of catheter-related vascular infection. Presented at the 24th International Congress on Antimicrobial Agents and Chemotherapy. Washington, DC, October 1984, Abstract #369.
  23. Belani AK, Sherertz RJ, Koo LC, Getchius JM, Rand KH. Sonication(s) as a method of quantitative vascular catheter (c) culture. Abstr Annu Meet Am Soc Microbiol 1985;379.
  24. Raad I, Sherertz R, Loveless M, Gotuzzo E, O'Connor R, Miller M, Mostow S. Cefpimizole (CF) in the treatment (T) of acute uncomplicated gonorrhea. Presented at the 25th International Congress on Antimicrobial Agents and Chemotherapy, Minneapolis. September, 1985. Abstract #503.
  25. Ekenna O, Getchius J, Koo L, Sherertz R. Factors affecting C. albicans colonization (CAC) of the GI-tract in mice. Presented at the 25th International Congress on Antimicrobial Agents and Chemotherapy, Minneapolis . September, 1985. Abstract #916.
  26. Ekenna O, Sherertz R, Getchius J, Koo L, Mahaffey S, Sitren H. A model of C. albicans dissemination from the gut of mice. Presented at the 25th International Congress on Antimicrobial Agents and Chemotherapy, Minneapolis . September, 1985. Abstract #917.
  27. Sherertz R, Koo L. Relationship of aspergillus (A) air counts (C) to different methods of hospital air filtration. Presented at the 25th International Congress of Antimicrobial Agents and Chemotherapy, Minneapolis. September, 1985. Abstract #945.
  28. Sherertz R, Cusick J, Fauerbach L, Reumen P, Belcuore T, Rains C. Impact of a community measles (M) outbreak (O) on a university hospital. Presented at the 25th International Congress on Antimicrobial Agents and Chemotherapy, Minneapolis. September, 1985. Abstract #937.
  29. Forman DM, Sherertz RJ, Solomon DD. Prevention of catheter insertion site infections by catheter bound antibiotic. Presented at the 26th International Congress on Antimicrobial Agents and Chemotherapy, New Orleans . September, 1986. Abstract #546.
  30. Stout L, Sherertz RJ. Hepatitis B vaccine efficacy vs injection site and duration of follow up. Presented at the 26th International Congress on Antimicrobial Agents and Chemotherapy, New Orleans. September, 1986. Abstract #985.
  31. Sherertz RJ, Belani A, Rand KH. Relationship between sonication vascular catheter cultures and same day blood cultures. Presented at the 26th International Congress on Antimicrobial Agents and Chemotherapy, New Orleans . September, 1986. Abstract #1132.
  32. Fauerbach LL, Straub SA, Sherertz RJ. The relationship between available resources in the practice of infection control in hospital and nursing homes in Florida. Presented at the 14th Annual Education Conference at the American Practitioners of Infection Control, May 1987, Miami, Florida.
  33. Pickett D, Fauerbach L, Sherertz R, Glaser D. Pseudomonas aeruginosa (PA) contamination in tap water of a bone marrow transplant unit (BMTU). Abstr Annu Meet Am Soc Microbiol 1988;413.
  34. Sherertz RJ, Van Mierop PW, Casey MM, Solomon DD, Byron MP. Efficacy of dicloxacillin coated vascular catheters at preventing S. aureus subcutaneous infection in a rabbit model. Presented at the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy, October 1988, Los Angeles. Abstract #376.
  35. Ramphal R, Oblon D, Sherertz RJ, Rand KH, Shands JW, Kramer BS, Bolger M, Malone J. Should vancomycin be combined with ceftazidime as empiric therapy in febrile neutropenic patients. Presented at the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. October 1988, Los Angeles , #14.
  36. Falk PS, Sherertz RJ, Scuderi PE. Infected radial artery aneurysms. Presented at the 16th Annual Education Conference at the American Practitioners of Infection Control, Reno, Nevada, May 1989.
  37. Clements JS, Hampton KD, Wasilauskas BL, Sherertz RJ. Impact of universal precautions on the acquisition of gentamicin-resistant gram negative bacilli in a university intensive care unit. Presented at the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston, Texas, September 1989. Abstract #787.
  38. Raad I, Sabbagh M, Rand KH, Sherertz RJ. Diagnosis of catheter related infections: comparison of the sonication and role plate semiquantitative techniques. Presented at the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston, Texas, September 1989. Abstract #1073.
  39. Marosok R, Carruth B, Washburn R, Solomon D, Sherertz R. Opsonic requirements for the killing of S. aureus on vascular catheter surfaces made of different materials. Presented at the American Federation of Clinical Research, Washington, D.C. Abstract #391A, 1990.
  40. Sherertz RJ, Abramson JS, Dillard RG, Givner LB, Gledhill LK, Hampton KS. An outbreak of candidemia associated with retrograde medication administration in a neonatal intensive care unit. Presented at the Third International Conference on Nosocomial Infections. Atlanta, GA, 1990.
  41. Sherertz RJ, Carruth W, Hu Q, Solomon DD. Factors modifying the risk of Staphylococcus aureus infection associated with silicone catheters in a rabbit model. Presented at the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. October 1990, Atlanta, Abstract #29.
  42. Abramson JS, Sherertz RJ, Hampton KD, Gledhill LK, Givner LB, Dillard RG. Outbreak of candidemia due to retrograde medication administration in a neonatal intensive care unit. Presented at the Society for Pediatric Research. May 1991, New Orleans, Abstract #1655. Ped. Res 29:279A.
  43. Marosok R, Solomon DD, Sherertz R. Vascular catheter thrombogenesis: enhancement by silicone surfaces and staphylococcal colonization. Presented at the American Federation for Clinical Research. May 1991, Clinical Res 39:243A.
  44. Williford PM, Sherertz EF, Sherertz RJ. Emergence of staphylococcus aureus in a new dermatology clinic. Presented at the American Academy of Dermatology, Monterey, California, June 1991.
  45. Sherertz RJ, Carruth WA, Byron MP, Solomon DD. Correlation of Kirby-Bauer zones of inhibition produced by anti-infective catheters (C) with efficacy at preventing subcutaneous Staphylococcus aureus (SA) infection (I) in a rabbit model (RM). Presented at the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. October 1991, Chicago. Abstract #1069.
  46. Carruth WA, Bryon MP, Solomon DD, White W, Sherertz RJ. Catheter (C)-associated inflammation (I) in a rabbit model (RM) with or without Staphylococcus aureus. Presented at the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. October 1991, Chicago. Abstract #1070.
  47. Stephens J, Rich HA, Carruth WA, Marosok R, Hampton K, Motsinger S, Harris L, Scuderi P, Sherertz RJ. Randomized double-blind trial comparing the risk of peripheral vein thrombophlebitis (T) between chlorhexidine (CHA) coated catheters (C) with uncoated control C. Presented at the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. October 1991. Abstract #1071.
  48. Gledhill KS, Thomas JS, Streed SA, Sherertz RJ. Development of an infection control practices tool to assess compliance at the bedside. Presented at the APIC Annual Meeting, San Francisco, California, September 1992.
  49. Sherertz R, Heard S, Raad I, Gentry L. Culturing catheter tips is an insensitive method for diagnosing triple lumen vascular catheter infection. Presented at the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. October 1992, Anaheim, California. Abstract #818.
  50. Sherertz RJ, Hu Q, Morykwas MJ, Argenta LC, Felton SC. Silicone breast implants have an enhanced risk of infection in a rabbit model of subcutaneous staphylococcus aureus infection that is not augmented by silicone breast implant gel. Presented at the 1993 Annual Meeting of the Infectious Diseases Society of America. October 1993, New Orleans. Poster #48.
  51. Sherertz R, Hu Q, Clarkson L, Felton S. The chlorhexidine on arrow catheters may be more important than Ag sulfadiazine at preventing catheter-related infections. Presented at the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. October 1993, New Orleans. Abstract #1622.
  52. Sherertz R, Heard S, Raad SI, Gentry L. Triple lumen catheters coated with a low concentration of chlorhexidine were not efficacious at preventing catheter infections. Presented at the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. October 1993, New Orleans. Abstract #1623.
  53. Indorf A, Clarkson L, Sherertz R. Neutrophil chemotaxis on polymer surfaces. Presented at the 33rd Interscience Conference in Antimicrobial Agents and Chemotherapy. October 1993, New Orleans. Abstract #552.
  54. Craver D, Hodges L, Hutcherson K, Sherertz R, Street S, Morris D, Leake T. Baxter infustion pumps and needleless tubings/devices have lower infection control risks and costs for intravenous therapy than Abbott infusion pumps and needleless tubings/devices. Presented at the APIC '94 Meeting, Cincinnati, Ohio, May 1994.
  55. Gledhill KS, Streed SA, Rushing JT, Sherertz RJ. Impact of compliance data on infection control practices after feedback to nursing staff educators. Presented at the 3rd International Conference of the Hospital Infection Society, London, England, September 1994.
  56. Raad I, Hachem R, Sherertz R. Minocycline-EDTA flush solution for the presentation of vascular catheter infections. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, October 1994, Abstract #J57.
  57. Sherertz RJ, Hampton KD. For sputum obtained from intubated patients visual determination of purulence correlates poorly with microscopic analysis. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, October 1994, Abstract #J170.
  58. Duran LW, Jenderko JA, Jelle BM, Sherertz RJ. Efficacy of antimicrobial coatings for cardiovascular devices. Presented at the American Society for Microbiology Meeting, Washington, DC, May 1995. Abstract #L2.
  59. Sherertz RJ, Reagan DS, Hampton KD, Robertson KL, Hoen HM, Streed SA. A nosocomial outbreak of methicillin-resistant staphylococcus aureus (MRSA) associated with nasal carriage by a physician. Presented at the Association for Professionals in Infection Control, Las Vegas, Nevada, June 1995.
  60. Sherertz RJ, Reagan D, Hampton K, Robertson K, Streed S, Hoen H, Thomas R, Gwaltney J. Cloud Adult: Staphylococcus aureus - viral interaction revisited. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, California, September 1995.
  61. Sherertz RJ. Enhanced risk of infection associated with silicone polymers. Presented at the Surfaces in Biomaterials Meeting, Minneapolis, Minnesota, September 1995.
  62. Sherertz R, Reagan D, Hampton K, Robertson K, Streed S, Hoen H, Thomas R, Gwaltney J, Quillen JH. Cloud adult: the Staphylococcus aureus – viral interaction revisited. Presented at the 6th Annual Meeting of the Society for Healthcare Epidemiology of American, Washington DC, April, 1996. Abstract #M90.
  63. Raad I, Hachem R, Sherertz R. Efficacy of minocycline/EDTA flush in preventing catheter-related bacteremia and septic phlebitis in rabbits. Presented at the 36th Annual Meeting of the Interscience Conference on Antimicrobial Agents and chemotherapy, New Orleans, September 1996, Abst4ract #J137.
  64. Sherertz R. Anti-infective coatings can decrease the risk of infection associated with foreign bodies. Presented at the 8th European Congress of Clinical Microbiology and Infectious Diseases. Larsanne, Switzerland, May 1997, Abstract #5161.
  65. Sherertz RJ, Streed SA, Gledhill KS, Hampton K, Koontz AJ. Accuracy of nosocomial infection (NI) surveillance as performed by infection control (IC) or quality improvement (QI) personnel. Infect Control Hosp Epidemiol 1998;19:687.
  66. Sherertz RJ, Westbrook DM, Gledhill KS, Streed SA. Description of an infection control course for house officers (HO) and medical students (MS). Infect Control Hosp Epidemiol 1998;19:682.
  67. Gledhill KS, Streed SA, Westbrook DT, Lawson JM, Adkins CL, Robertson KO, Sherertz RJ. A successful methicillin-resistant staphylococcus-aureus control program. Presented at the 4th International Conference of the Hospital Infections Society, Edinburg, Scotland, September 1998, Abstract P.3.1.6.1.
  68. Westbrook DM, Sherertz RJ, Gledhill KS, Streed SA. Development of an infection control course for house officers and medical students. Presented at the 4th International Conference of the Hospital Infections Society, Edinburg, Scotland, September 1998, Abstract P.11.1.2.
  69. Bassetti S, Sherertz RJ. Zones of inhibition of coated vascular catheters predict efficacy in preventing Staphylococcus aureus infections in vivo. Presented at the 9th Society for Healthcare Epidemiology of American Meeting, San Francisco, April 1999, Abstract #51.
  70. Nesky MA, Gaither B, Sherertz RJ. Blood cultures through vascular catheters – A reassessment. Presented at the 9th Society for Healthcare Epidemiology of American Meeting, San Francisco, April 1999, Abstract #M5.
  71. Basetti S, Hu J, Sherertz RJ. Increase in chlorhexidime concentration results in longer lasting in vivo efficiency of coated vascular catheters. Presented at the Infectious Disease Society of American Meeting, Philadelphia, November 1999. Abstract #454.
  72. Sherertz RJ, Chilton F, Cruz J, Whealton L. An after school science program for middle school children. Presented at the Infectious Disease Society of American Meeting, Philadelphia, November 1999. Abstract #596.
  73. Bleyer A, Mason L, Raad I, Sherertz RJ. A randomized, double-blind trial comparing heparin vs minocycline/EDTA as flush solutions for hemodialysis catheters. Presented at the 4th Decennial International Conference of Nosocomial and Healthcare-Associated Infections, Atlanta, 2000, Abstract # _____.
  74. Bassetti S, Dunagan DP, Sherertz RJ. Nasal carriage of Staphylococcus aureus among patients receiving allergen injection immunotherapy: prevalence, associated factors, and quantitative nasal cultures. Presented at the 4th Decennial International Conference of Nosocomial and Healthcare-Associated Infections, Atlanta, 2000, Abstract # _____.

Letters to the Editor:

  1. Sherertz RJ, Spindel E. Antibody to hepatitis B surface antigen may not always indicate immunity to hepatitis B virus infection. N Engl J Med 1983;309:1519. (Letter)
  2. Sherertz RJ, Streed SA. Letter to the Editor. N Engl J Med 1994;331:1659. (Letter)
  3. Sherertz RJ, Streed SA. Medical Devices: Significant vs Nonsignificant Risk. JAMA 1995;273:1906-7. (Letter)

 

 

 

 

Copyright: Wake Forest University School of Medicine and North Carolina Baptist Hospitals. All rights reserved.

Medical Center Boulevard

Winston-Salem, NC 27157

The information on this Website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified healthcare provider. If you have a medical problem or a health-related question, consult your physician or call Health On-Call at 336-716-2255 or 1-800-446-2255.

Send Feedback


Home

Site Index

Last Modified: 11/10/2005